GLAXF GSK plc

NEUTRAL Impact: 2/10 6-K
Horizon days Filed May 5, 2026 Processed 1mo ago SEC 0001654954-26-004342
Notable filing: 6-K
Latest settled — T+20d
GLAXF ▼ -4.28% at T+20d
NEUTRAL call ✗ call lost -4.28% · α vs SPY -9.23% · entry $25.01 → $23.94
Next anchor: T+60d in 7w
Currently $26.63 · +6.48% from $25.01 entry
Entry anchored
May 5, 2026
via day open
T+1d
+1.00%
call +1.00% · α -0.39%
$25.26
settled 5w ago
T+5d
+1.84%
call +1.84% · α -0.15%
$25.47
settled 5w ago
T+20d
-4.28%
call -4.28% · α -9.23%
$23.94
settled 10d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

GSK granted a deferred investment award of notional ordinary shares to new Chief People Officer Roanne Parry under its long-term incentive program. The award vests in 2028 and 2029, with no cash outlay or material dilution. This is a routine equity grant for a newly appointed executive.

Actionable Insight

This filing is routine and has no immediate trading implications. Monitor GSK's upcoming earnings and pipeline updates for material catalysts. The award reflects standard retention compensation for a new executive hire.

Key Facts

  • Grant of notional ordinary shares to Roanne Parry, newly appointed Chief People Officer and Executive Committee member.
  • Award valued at £19.01 per share for 35,507.628 notional shares.
  • Vesting schedule: 34.22% vests on 31 August 2028, 65.78% vests on 31 August 2029.
  • Award will be settled in cash on vesting; dividends accrue during vesting period.

Financial Impact

Not material; the notional award value is approximately £675,000 based on the grant price.

dilutioncompensation expense

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
41% bullish (32 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-004342
Document: 0001654954-26-004342-index-headers.html0001654954-26-004342
Document: 0001654954-26-004342-index.html0001654954-26-004342
Document: 0001654954-26-004342.txt0001654954-26-004342
51 reports for GLAXF
Performance horizon
42% Hit rate 5 of 12 directional calls best @ T+5▲ +7.60%Apr 1, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
Type Now
Jun 10, 2026
2d ago
6-K
NEUTRAL ★ 1/10
$23.54 awaiting T+5awaiting T+5$26.63 (+13.13%)
Jun 9, 2026
3d ago
6-K
NEUTRAL ★ 1/10
$24.66 awaiting T+5awaiting T+5$26.63 (+7.99%)
Jun 9, 2026
4d ago
6-K
BULLISH ★ 7/10
$24.66 awaiting T+5awaiting T+5$26.63 (+7.99%)
Jun 1, 2026
11d ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.63 (+9.81%)
Jun 1, 2026
11d ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.63 (+9.81%)
May 28, 2026
16d ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$26.63 (+8.34%)
May 27, 2026
16d ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$26.63 (+4.15%)
May 26, 2026
17d ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.63 (+4.43%)
May 26, 2026
17d ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.63 (+4.43%)
May 22, 2026
22d ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$26.63 (+2.42%)
Showing 10 of 51

US Market Status

Market Closed — Opens Mon (49h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access